NAS:OMCL (USA)
Business Description
Omnicell Inc
NAICS : 621999
SIC : 8099
590 East Middlefield Road, Mountain View, CA, USA, 94043
Description
Omnicell provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.42 | |||||
| Equity-to-Asset | 0.51 | |||||
| Debt-to-Equity | 0.57 | |||||
| Debt-to-EBITDA | 4.07 | |||||
| Interest Coverage | 4.62 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 4.03 | |||||
| Beneish M-Score | -2.04 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 6.7 | |||||
| 3-Year EBITDA Growth Rate | 15.5 | |||||
| 3-Year EPS without NRI Growth Rate | 20.3 | |||||
| 3-Year FCF Growth Rate | 43.6 | |||||
| 3-Year Book Growth Rate | 15.5 | |||||
| Future 3-5Y Total Revenue Growth Rate Industry Rank | 15.31 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 60.34 | |||||
| 9-Day RSI | 54.44 | |||||
| 14-Day RSI | 51.36 | |||||
| 6-1 Month Momentum % | -18.04 | |||||
| 12-1 Month Momentum % | -27.02 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.11 | |||||
| Quick Ratio | 1.71 | |||||
| Cash Ratio | 0.69 | |||||
| Days Inventory | 68.47 | |||||
| Days Sales Outstanding | 74.62 | |||||
| Days Payable | 38.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.04 | |||||
| Operating Margin % | 4.66 | |||||
| Net Margin % | 4.82 | |||||
| ROE % | 5.53 | |||||
| ROA % | 2.91 | |||||
| ROIC % | 4.49 | |||||
| ROC (Joel Greenblatt) % | 27.65 | |||||
| ROCE % | 3.88 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 88.26 | |||||
| PE Ratio without NRI | 88.26 | |||||
| Shiller PE Ratio | 114.84 | |||||
| PEG Ratio | 6.95 | |||||
| PS Ratio | 4.24 | |||||
| PB Ratio | 4.48 | |||||
| Price-to-Tangible-Book | 556.05 | |||||
| Price-to-Free-Cash-Flow | 364.61 | |||||
| Price-to-Operating-Cash-Flow | 72.33 | |||||
| EV-to-EBIT | 90.32 | |||||
| EV-to-EBITDA | 34.68 | |||||
| EV-to-Revenue | 4.22 | |||||
| EV-to-Forward-Revenue | 3.82 | |||||
| EV-to-FCF | 301.19 | |||||
| Price-to-Projected-FCF | 3.44 | |||||
| Price-to-DCF (Earnings Based) | 3.96 | |||||
| Price-to-DCF (FCF Based) | 26.78 | |||||
| Price-to-Median-PS-Value | 1.52 | |||||
| Price-to-Peter-Lynch-Fair-Value | 5.42 | |||||
| Price-to-Graham-Number | 47.07 | |||||
| Earnings Yield (Greenblatt) % | 1.1 | |||||
| Forward Rate of Return (Yacktman) % | 17.57 |
Guru Trades
See DetailsEMBED
SAVE
Insider Trades
See DetailsEMBED
SAVE
Gurus Latest Trades with NAS:OMCL
Executives
EMBED
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1,257.65 | ||
| EPS (TTM) ($) | 1.26 | ||
| Beta | 0.97 | ||
| Volatility % | 35.56 | ||
| 14-Day RSI | 51.36 | ||
| 14-Day ATR ($) | 3.6872 | ||
| 20-Day SMA ($) | 110.2585 | ||
| 12-1 Month Momentum % | -27.02 | ||
| 52-Week Range ($) | 103.62 - 187.285 | ||
| Shares Outstanding (Mil) | 44.29 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Omnicell Inc Filings
| Document | Form | Filing Date | ||
|---|---|---|---|---|
| No Filing Data | ||||